A prostate cancer diagnosis is only the beginning of understanding the disease. Doctors also need to determine how extensive the cancer is, whether it remains within the prostate, and whether it has spread elsewhere. This process is called staging of prostate cancer. The stage helps the medical team assess the cancer’s extent and discuss treatment options that are appropriate for the individual’s condition.
What Is the Staging of Prostate Cancer?
Cancer staging describes how far a cancer has developed or spread in the body. For prostate cancer, doctors consider the size and location of the tumour, whether nearby lymph nodes are involved, and whether the cancer has spread to distant organs or bones.
Prostate cancer staging commonly considers:
- The primary tumour (T): Whether the cancer is confined to the prostate or has grown into nearby tissues.
- Nearby lymph nodes (N): Whether cancer cells have spread to regional lymph nodes.
- Distant metastasis (M): Whether the cancer has spread to distant parts of the body.
- PSA level: The amount of prostate-specific antigen in the blood provides important information about the disease.
- Grade or Grade Group: This describes how abnormal the cancer cells look under a microscope and how aggressively they are likely to behave.
Together, these findings provide a more complete picture than any single test alone.
Why Is Staging Important?
Knowing the cancer stage helps doctors understand the extent of the disease and estimate how it may behave. It also provides an important framework for discussing treatment options.
Staging may help:
- Distinguish cancer confined to the prostate from cancer that has spread.
- Determine whether surgery, radiotherapy, systemic treatment, active surveillance, or a combination may be appropriate.
- Identify whether lymph nodes or other areas require assessment or treatment.
- Provide information about the likely course of the disease.
- Help doctors monitor the cancer over time.
The stage is not the only factor considered when making treatment decisions. Overall health, age, PSA level, Grade Group, imaging findings, symptoms, and personal preferences may also influence the recommended approach.
Who Should Consider Staging?
Staging is generally part of the assessment after prostate cancer has been confirmed, although the extent of testing depends on the characteristics of the cancer.
Staging assessment may be particularly relevant for men who:
- Have prostate cancer confirmed by biopsy.
- Have a higher PSA level.
- Have a higher Grade Group or other features suggesting more aggressive disease.
- Have findings on examination that suggest the cancer may extend beyond the prostate.
- Have symptoms or imaging findings that raise concern about spread.
- Are being evaluated for treatment following diagnosis.
Not every patient requires every staging investigation. The tests selected depend on the risk and characteristics of the cancer.
Who Should Seek Medical Advice First?
If prostate cancer has been diagnosed, staging should be discussed with a urologist or appropriate cancer specialist before treatment decisions are made.
Additional assessment may be particularly important if you:
- Have a significantly elevated PSA level.
- Have an abnormal prostate examination.
- Have a high-grade or higher-risk tumour on biopsy.
- Have bone pain or other symptoms that could indicate advanced disease.
- Have already undergone prostate cancer treatment.
- Have other medical conditions that may affect treatment choices.
Your doctor can explain which investigations are appropriate and why they are being recommended.
What Tests Are Used for Staging of Prostate Cancer?
Several investigations may contribute to staging. The choice depends on the suspected risk and whether there is concern that the cancer has spread.
PSA blood test
PSA is a protein produced by prostate cells. A raised PSA level can occur with prostate cancer, although it can also increase because of benign prostate enlargement, inflammation, infection, or other causes.
After diagnosis, the PSA level contributes to risk assessment and helps doctors interpret other findings.
Prostate biopsy
A biopsy involves removing small samples of prostate tissue for examination under a microscope. It confirms whether cancer is present and provides information about the cancer’s grade.
The Grade Group helps describe how likely the cancer is to grow and spread.
MRI scan
Multiparametric MRI can provide detailed images of the prostate and surrounding tissues. It may help determine whether a tumour appears confined to the prostate or has grown beyond it.
CT or other imaging
CT scans may be used in selected patients to assess lymph nodes or other areas when there is concern about more extensive disease.
Bone imaging
Because prostate cancer can spread to bone, bone imaging may be recommended for selected patients with higher-risk disease or symptoms suggesting possible bone involvement.
PSMA PET imaging
In some circumstances, prostate-specific membrane antigen (PSMA) PET imaging may be used to look for prostate cancer cells elsewhere in the body. Availability and suitability depend on the clinical situation.
How Is Prostate Cancer Staged?
Doctors commonly use the TNM system to describe the extent of prostate cancer.
The T stage describes the primary tumour. It considers whether the cancer is limited to the prostate or has extended into nearby structures.
The N stage indicates whether regional lymph nodes contain cancer.
The M stage describes whether the cancer has spread to distant parts of the body, such as bones or other organs.
Doctors then combine these findings with PSA levels and Grade Group to assign an overall risk and stage grouping.
Broadly, prostate cancer may be described as:
Localised: Cancer remains within the prostate.
Locally advanced: Cancer has grown outside the prostate into nearby tissues or structures.
Metastatic: Cancer has spread to distant parts of the body.
The exact stage is more detailed than these broad categories, so patients should discuss their individual staging results with their urologist.
How Should You Prepare?
Preparation depends on which staging tests are recommended. Some scans require specific instructions, while others require little preparation.
Before your investigations, you may need to:
- Provide a complete list of medications and supplements.
- Inform your doctor about allergies.
- Mention kidney problems or other significant medical conditions.
- Bring previous imaging or biopsy reports when available.
- Follow any fasting or preparation instructions.
- Ask when and how the results will be discussed.
If contrast material is required for an imaging test, your healthcare team will explain any relevant precautions.
What Happens During Staging?
Staging does not usually involve one single appointment or procedure. Instead, the urologist reviews the available information and determines whether additional investigations are needed.
The process may involve:
- Reviewing your PSA results and medical history.
- Performing or reviewing a prostate examination.
- Assessing the biopsy findings and Grade Group.
- Reviewing prostate MRI or other imaging.
- Ordering additional scans when clinically indicated.
- Combining the results to determine the extent of the cancer.
- Discussing the stage and treatment options with you.
The timeframe varies depending on the investigations required and how quickly results become available.
Benefits, Risks, and Possible Side Effects
Accurate staging helps doctors select treatment based on the extent and characteristics of the cancer rather than relying on the biopsy result alone.
Potential benefits include:
- A clearer understanding of how extensive the cancer is.
- Better-informed treatment planning.
- Identification of cancer that may have spread.
- A baseline for future monitoring.
The risks depend on the investigations performed. A biopsy may cause temporary discomfort, bleeding, or infection. Imaging tests generally have few risks, although some involve radiation exposure or contrast material. Your healthcare team can explain the specific risks associated with each test.
What Our Urology Team Says
Patients often find the staging process confusing because several test results contribute to the final assessment. We explain each result in context rather than relying on a single number or scan. PSA levels, biopsy findings, Grade Group, MRI results, and other imaging can each provide different information about the cancer. During consultation, we review these findings together and discuss what they mean for the individual’s diagnosis. Treatment decisions are then considered according to the cancer’s extent, overall health, and personal circumstances, with the aim of ensuring that patients understand the options available to them.
Putting This Into Practice
- Keep copies of your PSA and biopsy results.
- Ask your urologist what Grade Group was identified.
- Understand whether the cancer is localised or has spread.
- Ask why particular staging scans have been recommended.
- Discuss how the stage affects your treatment options.
- Keep scheduled follow-up appointments.
When to Seek Professional Help
Seek medical advice if you:
- Develop new or worsening urinary symptoms.
- Experience unexplained blood in the urine.
- Develop persistent bone or back pain.
- Experience unexplained weight loss or significant fatigue.
- Notice new weakness, numbness, or difficulty walking.
- Have concerns about changes in your symptoms following diagnosis.
Frequently Asked Questions
What is the purpose of staging prostate cancer?
The purpose of staging of prostate cancer is to determine how far the cancer has spread. Doctors assess the primary tumour, nearby lymph nodes, and distant areas of the body, together with PSA and Grade Group. This information helps the medical team understand the disease and determine which treatment options may be appropriate.
Is a high PSA level enough to determine the cancer stage?
No. PSA alone cannot determine the stage of prostate cancer. A higher PSA can provide information about the cancer and its risk, but doctors also consider biopsy findings, Grade Group, examination results, and imaging. These findings are assessed together to determine the extent of the disease.
Does prostate cancer always require a scan after diagnosis?
No. The need for imaging depends on the characteristics and risk of the cancer. Men with lower-risk, localised disease may not require extensive staging scans, while imaging is more commonly considered when there is a higher risk of spread or symptoms suggesting more advanced disease.
What does Grade Group mean in prostate cancer?
Grade Group describes how abnormal prostate cancer cells appear under a microscope and provides information about how aggressively the cancer may behave. It ranges from Grade Group 1 to Grade Group 5. It is different from the cancer stage, although both are important when assessing the disease and planning treatment.
Can the stage of prostate cancer change?
The stage assigned at diagnosis generally describes the extent of cancer found at that time. However, prostate cancer can progress or recur after treatment, so doctors may perform further tests if there are concerns about changes in PSA, symptoms, or imaging. Ongoing monitoring helps identify changes that may require further assessment.
Next Steps
A prostate cancer diagnosis does not provide the complete picture by itself. Staging of prostate cancer combines information from PSA testing, biopsy results, Grade Group, physical examination, MRI, and other imaging when appropriate. These findings help determine whether the cancer is confined to the prostate, has extended into nearby tissues, or has spread elsewhere. The investigations required vary according to individual risk and clinical findings. If you have recently been diagnosed with prostate cancer or are unsure what your staging results mean, speak with your urologist. A personalised discussion can help you understand the diagnosis and consider the next steps in treatment.